- Page 1/6
He's been long underweight energy. Management has issued more stock and cut the dividend in recent years and broke promises. CPG managers used to be conservative, no longer. He prefers other names like Suncor which is resilient when oil prices slip.
He's been long underweight energy. Management has issued more stock and cut the dividend in recent years and broke promises. CPG managers used to be conservative, no longer. He prefers other names like Suncor which is resilient when oil prices slip.
Selling it literally today. It's a bad news story that he doesn't see getting better. He was patient, but now is moving on. It's down 19% YTD. The reasons are secondary; he doesn't see a turnaround.
Selling it literally today. It's a bad news story that he doesn't see getting better. He was patient, but now is moving on. It's down 19% YTD. The reasons are secondary; he doesn't see a turnaround.
Healthcare names are defensive and a portfolio needs them, but JNJ is flat YTD. If your portfolio is light in defensive names, then consider this. Buy according to your overall portfolio composition. Consumer and medical product
divisions have modest growth. Pharma is its big driver of growth.
Healthcare names are defensive and a portfolio needs them, but JNJ is flat YTD. If your portfolio is light in defensive names, then consider this. Buy according to your overall portfolio composition. Consumer and medical product
divisions have modest growth. Pharma is its big driver of growth.
Over 10 years, this will be fine. Less than that, you will be unimpressed by the share price, though you'll be collecting a decent 5% dividend. BCE gives you stability, not price appreciation. Over the long term, expect an overall 7-8%
yearly return and there's nothing wrong with that. A low-beta stock long-term.
Over 10 years, this will be fine. Less than that, you will be unimpressed by the share price, though you'll be collecting a decent 5% dividend. BCE gives you stability, not price appreciation. Over the long term, expect an overall 7-8%
yearly return and there's nothing wrong with that. A low-beta stock long-term.
It's hard making money owning it. He's not sure why Canadians keep banging their head buying MFC, when you can buy the Canadian banks. He has no specific criticism about MFC, and in fact MFC is doing a lot of things right, like
moving more into wealth management and performing well in Asia, while diversifying away from insurance. But there's a disconnect in what they're doing and the share price, which has been ongoing.
It's hard making money owning it. He's not sure why Canadians keep banging their head buying MFC, when you can buy the Canadian banks. He has no specific criticism about MFC, and in fact MFC is doing a lot of things right, like
moving more into wealth management and performing well in Asia, while diversifying away from insurance. But there's a disconnect in what they're doing and the share price, which has been ongoing.
A higher-beta bank name, because their revenues are mostly in Latin America where there are commodity-based economies and are thus more volatile. But the middle class is growing there, so there's long-term potential. You'll be fine if you have a medium- or long-term horizon, but challenging in the short. It's riskier than its peers. Also, it takes time to digest their recent large acquisitions in wealth management and to benefit from those synergies.
A higher-beta bank name, because their revenues are mostly in Latin America where there are commodity-based economies and are thus more volatile. But the middle class is growing there, so there's long-term potential. You'll be fine if you have a medium- or long-term horizon, but challenging in the short. It's riskier than its peers. Also, it takes time to digest their recent large acquisitions in wealth management and to benefit from those synergies.
The conventional, safe American bank with a good balance between retail and investment banking. But we are in the late stages of the economic cycle. The U.S. economy is strong, but this year's gains were spurred by last year's tax cuts. So what's the catalyst for 2019? BAC's lending book has to accept more risk going forward. This isn't the time to load up on U.S. financials. Be cautious. We're late in the cycle.
The conventional, safe American bank with a good balance between retail and investment banking. But we are in the late stages of the economic cycle. The U.S. economy is strong, but this year's gains were spurred by last year's tax cuts. So what's the catalyst for 2019? BAC's lending book has to accept more risk going forward. This isn't the time to load up on U.S. financials. Be cautious. We're late in the cycle.